Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Three small cap new issues are currently flying high

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
A trio of recently floated small caps have seen their shares perform extremely well since IPO, confirmation that new issues with compelling growth narratives can deliver impressive rapid-fire returns.
Swiss-based environmentally-minded materials company HeiQ (HEIQ) debuted on the Main Market on 7 December following a £60 million raise at 112p and has more than doubled to 240.3p on excitement surrounding technology that adds functionality to textiles, be it improving cooling, warming or even odour prevention.
Moreover, the company’s antiviral surface protection effectively kills off infectious diseases such as Covid-19. HeiQ’s clients including IKEA, where it helps produce curtains to purify the air, as well as Burberry (BRBY), Zara and The North Face.
Also flying high is Calnex Solutions (CLX:AIM), a provider of test and measurement solutions for the telecommunications sector with a customer roster that includes BT (BT.A), Ericsson, Nokia and Facebook. Debuting on AIM in October after raising £22.5 million at 48p, its shares have dialled up a 145% gain to 117.5p, investors impressed by news of a 90% first half pre-tax profit increase to over £2.3 million.
Another in rude health is Verici Dx (VRCI:AIM), which floated (3 Nov) via an oversubscribed fundraising at 20p and now trades at 92p. Sara Barrington-bossed Verici Dx develops tests to understand how a patient is likely to, and may be, responding to a kidney transplant.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.